Driving Innovation and Improving Business Process  

Underforecasting: How and Why Product Sales are Underestimated

John Ansell, Senior Partner, TranScrip; Author, "Transforming Big Pharma – Assessing the Strategic Alternatives"

Productivity Improvement through Integrated Business Planning (IBP)

Rafiqul Islam, Senior Director, Global Bioanalytical Services, Celerion, Inc.

Talk Title to be Announced  

Peter Heinrich, CEO, PDWare

Resource Management and Uncertainty 

Case Study: Strategic Resource Management during a Major Restructuring Program

Hartmut Hein, Ph.D., Director, Head of Global Planning Office, Merck Serono (EMD Serono)

Factors that Influence Portfolio Decisions

Anastasia Christianson, Ph.D., Senior Director, R&D Information, AstraZeneca

Role of Uncertainty in Biopharmaceutical R&D Portfolio Decision Making

Daniel Zweidler, Ph.D., Senior Fellow, Mack Center for Technological Innovation, Wharton School

Strategic Portfolio Optimization in Reality  

Speaker to be Announced

Efficient Resource Management in Internal and External Development 

Efficient Resource Management in Medium-Scale Biotech R&D: Setting Goals and Achieving Them

Frank Rebers, Ph.D., Associate Director, Project Management, Genmab

Operational Excellence for R&D in Emerging Markets

Abhishek Mittal, Assistant General Manager, R&D Operations and Project Management, Syngene International Ltd.

The Unintended Consequences of Co-Development of Pipeline Products

James Carlson, Senior Director, Program Management and Due Diligence, Shire Regenerative Medicine

The New Discipline of Project Portfolio Management: The Seven Components of Success

Michael Menard, President, CEO, Executive, The GenSight Group; Author: "A Fish in Your Ear: The New Discipline of Project Portfolio Management"

What Public Sector and Private Industry Can Learn from Each Other 

Federal Case Study: Multi-Million Dollar Data Center Program Management, Capacity Planning and Decision Making

Brian Bissett, IT Specialist, Office of Systems/CIO, Social Security Administration

Analyzing Investments in Biomedical Research at NIH

George Santangelo, Ph.D., Director, Office of Portfolio Analysis (OPA), Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), The National Institutes of Health (NIH)

A Consumer's Guide to Research about Resource Allocation and Portfolio Management

Jeffrey Keisler, Ph.D., Professor, MSIS Dept., College of Management, University of Massachusetts Boston

PANEL DISCUSSION

A Partnering Perspective: Comparing Pharmaceutical and Device Industry R&D Investment Decision Making with Government and Non-Profit Program Evaluation Methods for Biomedical Research

Chair: Steven Greidinger, Public-Private Healthcare Ventures

Panelists: George Santangelo, Ph.D., Director, Office of Portfolio Analysis (OPA), Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), The National Institutes of Health (NIH)

Shama Kajiji, Ph.D., MBA, Director, Strategy and Portfolio Integration, Janssen Pharmaceuticals R&D

Additional panelists to be announced